Comparison between Fortis Healthcare IPO and Insecticides IPO.
Fortis Healthcare IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Insecticides IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Fortis Healthcare IPO is up to ₹494.14 Cr whereas the issue size of the Insecticides IPO is up to ₹36.92 Cr. The final issue price of Fortis Healthcare IPO is ₹108.00 per share and of Insecticides IPO is ₹115.00 per share.
| Fortis Healthcare IPO | Insecticides IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹92.00 per share | ₹97.00 per share |
| Issue Price (Upper) | ₹110.00 per share | ₹115.00 per share |
| Issue Price (Final) | ₹108.00 per share | ₹115.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 60 shares | 60 shares |
| Fresh Issue Size | 4,57,53,963 shares | 32,10,266 shares |
| Fresh Issue Size (Amount) | up to ₹494.14 Cr | up to ₹36.92 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 4,57,53,963 shares | 32,10,266 shares |
| Issue Size Total (Amount) | up to ₹494.14 Cr | up to ₹36.92 Cr |
Fortis Healthcare IPO opens on Apr 16, 2007, while Insecticides IPO opens on May 07, 2007. The closing date of Fortis Healthcare IPO and Insecticides IPO is Apr 20, 2007, and May 11, 2007, respectively.
| Fortis Healthcare IPO | Insecticides IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Apr 16, 2007 | May 07, 2007 |
| Issue Close | Apr 20, 2007 | May 11, 2007 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | May 09, 2007 | May 30, 2007 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Fortis Healthcare IPO P/E ratio is , as compared to Insecticides IPO P/E ratio of .
| Fortis Healthcare IPO | Insecticides IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 93.37 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 74.45 | 74.94 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹2448.00 Cr. | ₹145.85 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | -34 | 50.6 |
In the Fortis Healthcare IPO Retail Individual Investors (RII) are offered 1,37,26,189 shares while in Insecticides IPO retail investors are offered 1,37,26,189 shares. Qualified Institutional Buyers (QIB) are offered 2,74,52,378 shares in Fortis Healthcare IPO and 15,88,950 shares in Insecticides IPO.
| Fortis Healthcare IPO | Insecticides IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 2,74,52,378 shares | 15,88,950 shares |
| NII | 45,75,396 shares | 4,76,685 shares |
| RII | 1,37,26,189 shares | 11,12,265 shares |
| Employee | 32,100 shares | |
| Others | ||
| Total | 4,57,53,963 shares | 32,10,000 shares |
Fortis Healthcare IPO subscribed 2.78x in total, whereas Insecticides IPO subscribed 1.97x.
| Fortis Healthcare IPO | Insecticides IPO | |
|---|---|---|
| QIB (times) | 2.72x | 0.32x |
| NII (times) | 1.74x | 1.62x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.25x | 4.49x |
| Employee (times) | 1.21x | |
| Other (times) | ||
| Total (times) | 2.78x | 1.97x |
